Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1643
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Phytosomes: emergent promising nano vesicular drug delivery system for targeted tumor therapy
N Abdul Azeez,V Sudarshana Deepa,V Sivapriya
Advances in Natural Sciences: Nanoscience and Nanotechnology.2018;9(3)033001
[DOI]
2Oxaliplatin for the treatment of ovarian cancer
Stefano Bogliolo,Chiara Cassani,Barbara Gardella,Valentina Musacchi,Luciana Babilonti,Pier-Luigi Venturini,Simone Ferrero,Arsenio Spinillo
Expert Opinion on Investigational Drugs.2015;24(9)1275
[DOI]
3Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients
Patrizia Vici,Domenico Sergi,Laura Pizzuti,Luciano Mariani,Maria Grazia Arena,Maddalena Barba,Marcello Maugeri-Saccà,Cristina Vincenzoni,Enrico Vizza,Giacomo Corrado,Giancarlo Paoletti,Federica Tomao,Silverio Tomao,Diana Giannarelli,Luigi Di Lauro
Journal of Experimental & Clinical Cancer Research.2013;32(1)1275
[DOI]
4Gemcitabine–oxaliplatin (GEMOX) for epithelial ovarian cancer patients resistant to platinum-based chemotherapy
Mohamed Elshebeiny,Walid Almorsy
Journal of the Egyptian National Cancer Institute.2016;28(3)183
[DOI]
5The efficacy and safety of Oxaliplatin-Vinorelbine as a second-line chemotherapy combination in patients with platinum-resistant pretreated epithelial ovarian cancer: A retrospective study
Fidia Mumtahana,Xinli Tiang,Teng Zhang,Baoxia Cui
International Journal of Cancer Therapy and Oncology.2014;2(4)020413
[DOI]
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow